Cargando...

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease

Results from two randomised global trials (SOFT & TEXT) designed to newly define the most effective components of adjuvant endocrine therapy for premenopausal women with endocrine responsive disease, showed that for some, those with high risk of relapse, the use of the aromatase inhibitor exemes...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ecancermedicalscience
Main Authors: Goldhirsch, Aron, Colleoni, Marco, Regan, Meredith
Formato: Artigo
Idioma:Inglês
Publicado: Cancer Intelligence 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462884/
https://ncbi.nlm.nih.gov/pubmed/26082801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.544
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!